Jun‐Li Luo

7.0k total citations · 4 hit papers
47 papers, 5.5k citations indexed

About

Jun‐Li Luo is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Jun‐Li Luo has authored 47 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 19 papers in Cancer Research and 16 papers in Immunology. Recurrent topics in Jun‐Li Luo's work include NF-κB Signaling Pathways (12 papers), Immune Response and Inflammation (7 papers) and interferon and immune responses (4 papers). Jun‐Li Luo is often cited by papers focused on NF-κB Signaling Pathways (12 papers), Immune Response and Inflammation (7 papers) and interferon and immune responses (4 papers). Jun‐Li Luo collaborates with scholars based in China, United States and Germany. Jun‐Li Luo's co-authors include Michael Karin, Shin Maeda, Hyam L. Leffert, Hideaki Kamata, Sergei I. Grivennikov, Li‐Chung Hsu, Hiroyuki Takahashi, Wan‐Wan Lin, Youngjun Kim and Pascal Descargues and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Jun‐Li Luo

42 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IKKβ Couples Hepatocyte Death to Cytokine-Driven Compensatory Proliferation that Promotes Chemical Hepatocarcinogenesis

2005 948 citations Shin Maeda, Hideaki Kamata et al. profile →
Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis

2008 885 citations Jun‐Li Luo, Michael Karin et al. Nature profile →
IKK/NF- B signaling: balancing life and death - a new approach to cancer therapy

2005 712 citations Jun‐Li Luo Journal of Clinical Investigation profile →
B-cell-derived lymphotoxin promotes castration-resistant prostate cancer

2010 481 citations Jun‐Li Luo, Michael Karin et al. Nature profile →

Peers

Countries citing papers authored by Jun‐Li Luo

Since Specialization

Citations

This map shows the geographic impact of Jun‐Li Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun‐Li Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun‐Li Luo more than expected).

Fields of papers citing papers by Jun‐Li Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun‐Li Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun‐Li Luo. The network helps show where Jun‐Li Luo may publish in the future.

Co-authorship network of co-authors of Jun‐Li Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Jun‐Li Luo. A scholar is included among the top collaborators of Jun‐Li Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun‐Li Luo. Jun‐Li Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Risk factor of postoperative pulmonary complications after colorectal cancer surgery: an analysis of nationwide inpatient sample 2025 ·Scientific Reports ·Liping Huang, Jun‐Li Luo, Yifan Wang, Lu Gan, Nuo Xu, J. Paul Chen, (unknown)	2
2	The functions of FXYD family members in human health and disease 2025 ·Genes & Diseases ·Xi Li, (unknown), (unknown), Jun‐Li Luo	0
3	Potassium isotope constraints on brine sources and evolution in Qaidam Basin, Tibetan Plateau 2025 ·Ore Geology Reviews ·Maoyong He, (unknown), Jianzhou Chen, (unknown), Li Deng, (unknown), Jun‐Li Luo, Hanbing Rao	1
4	The role of GPI-anchored LY6/uPAR family proteins in connecting membrane microdomains with immune regulation and diseases 2025 ·Critical Reviews in Oncology/Hematology ·Jingyi Wen, (unknown), Shangwei Zhong, (unknown), Jun‐Li Luo	0
5	Triple-Negative Breast Cancer Intrinsic FTSJ1 Favors Tumor Progression and Attenuates CD8+ T Cell Infiltration 2024 ·Cancers ·(unknown), Qingqing Liu, Shangwei Zhong, Rui Wei, Jun‐Li Luo	3
6	DDX5 Functions as a Tumor Suppressor in Tongue Cancer 2023 ·Cancers ·Qingqing Liu, (unknown), Min Long, Xueyan Chen, Shangwei Zhong, Changhao Huang, Rui Wei, Jun‐Li Luo	3
7	Tumor-derived OBP2A promotes prostate cancer castration resistance 2022 ·The Journal of Experimental Medicine ·Ji-Hak Jeong, Shangwei Zhong, Fuzhuo Li, Changhao Huang, (unknown), (unknown), Shoujiao Peng, HaJeung Park, You Mie Lee, Jasreman Dhillon, Jun‐Li Luo	17
8	The Human Respiratory Microbiome: Current Understandings and Future Directions 2022 ·American Journal of Respiratory Cell and Molecular Biology ·Lan Zhao, Jun‐Li Luo, Md Khadem Ali, Edda Spiekerkoetter, Mark R. Nicolls	37
9	PRPF19 promotes tongue cancer growth and chemoradiotherapy resistance 2021 ·Acta Biochimica et Biophysica Sinica ·Yihong He, Changhao Huang, (unknown), Pei Liu, Xueyan Chen, Yunhua Xu, (unknown), Qingqing Liu, (unknown), Xue Xia, (unknown), Jun‐Li Luo, Rui Wei	13
10	A Simple and Efficient System for Producing Recombinant Human CXCL8 in Escherichia coli 2020 ·Journal of Interferon & Cytokine Research ·Changhao Huang, Shangwei Zhong, HaJeung Park, Ji-Hak Jeong, Jun‐Li Luo	2
11	Targeting Tumor Microenvironment by Small-Molecule Inhibitors 2019 ·Translational Oncology ·Shangwei Zhong, Ji-Hak Jeong, Zhikang Chen, Zihua Chen, Jun‐Li Luo	90
12	Intensity-modulated radiotherapy, volume-modulated arc therapy and helical tomotherapy for locally advanced nasopharyngeal carcinoma: a dosimetric comparison 2017 ·Translational Cancer Research ·Wen Chen, (unknown), (unknown), Zijian Zhang, (unknown), Yuxiang He, Jun‐Li Luo, Ying Liang, Rui Wei	2
13	Transcriptomics-based identification of <italic>WRKY</italic> genes and characterization of a salt and hormone-responsive <italic>PgWRKY1</italic> gene in <italic>Panax ginseng</italic> 2016 ·Acta Biochimica et Biophysica Sinica ·Mohammed Nuruzzaman, Hongzhe Cao, (unknown), Tiao Luo, Jijia Li, Xianghui Chen, Jun‐Li Luo, Zhiyong Luo	30
14	IL6-Mediated Suppression of miR-200c Directs Constitutive Activation of Inflammatory Signaling Circuit Driving Transformation and Tumorigenesis 2012 ·Molecular Cell ·Matjaž Rokavec, Weilin Wu, Jun‐Li Luo	127
15	Essential Cytoplasmic Translocation of a Cytokine Receptor–Assembled Signaling Complex 2008 ·Science ·Atsushi Matsuzawa, Ping‐Hui Tseng, Sivakumar Vallabhapurapu, Jun‐Li Luo, Weizhou Zhang, Haopeng Wang, Dario A.A. Vignali, Ewen Gallagher, Michael Karin	179
16	Nuclear cytokine-activated IKKα controls prostate cancer metastasis by repressing Maspin 2007 ·Nature ·Jun‐Li Luo, Wei Phin Tan, Jill M. Ricono, Olexandr Korchynskyi, Ming Zhang, Steven L. Gonias, David A. Cheresh, Michael Karin	337
17	The Anti-Death Machinery in IKK/NF-κB Signaling 2005 ·Journal of Clinical Immunology ·Jun‐Li Luo, Hideaki Kamata, Michael Karin	88
18	IKK/NF- B signaling: balancing life and death - a new approach to cancer therapy breakdown → 2005 ·Journal of Clinical Investigation ·Jun‐Li Luo	712
19	The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4 2004 ·Nature ·Li‐Chung Hsu, Jin Mo Park, Kezhong Zhang, Jun‐Li Luo, Shin Maeda, Randal J. Kaufman, Lars Eckmann, Donald G. Guiney, Michael Karin	313
20	Knock-in mice with a chimeric human/murine p53 gene develop normally and show wild-type p53 responses to DNA damaging agents: a new biomedical research tool 2001 ·Oncogene ·Jun‐Li Luo, Qin Yang, Wei‐Min Tong, Manfred Hergenhahn, Zhao‐Qi Wang, Monica Hollstein	108

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact